ĎURINÍKOVÁ, Anna, Ivana JEŽÍŠKOVÁ, A. FOLTA, Dagmar AL TUKMACHI, Zdeňka HERUDKOVÁ, Martin ČULEN, Dana DVOŘÁKOVÁ, Nikola TOM, P. CETKOVSKÝ, P. JINDRA, T. SZOTKOWSKI, P. ŽÁK, Jiří MAYER and Zdeněk RÁČIL. A quarter of NRAS positive patients carry multiple point mutations, each of them localised separately in different alleles. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A quarter of NRAS positive patients carry multiple point mutations, each of them localised separately in different alleles
Authors ĎURINÍKOVÁ, Anna (703 Slovakia, belonging to the institution), Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution), A. FOLTA (203 Czech Republic), Dagmar AL TUKMACHI (203 Czech Republic, belonging to the institution), Zdeňka HERUDKOVÁ (203 Czech Republic, belonging to the institution), Martin ČULEN (703 Slovakia, belonging to the institution), Dana DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution), Nikola TOM (203 Czech Republic, belonging to the institution), P. CETKOVSKÝ (203 Czech Republic), P. JINDRA (203 Czech Republic), T. SZOTKOWSKI (203 Czech Republic), P. ŽÁK (203 Czech Republic), Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, guarantor, belonging to the institution).
Edition 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere, 2018.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10606 Microbiology
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14740/18:00104471
Organization unit Central European Institute of Technology
Keywords in English NRAS; mutations; localised separately
Tags rivok
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 26/3/2019 15:38.
Abstract
A quarter of NRAS positive patients carry multiple point mutations, each of them localised separately in different alleles, A quarter of NRAS positive patients carry multiple point mutations, each of them localised separately in different alleles.
Links
MUNI/A/0968/2017, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A
PrintDisplayed: 20/8/2024 03:28